Simon Quick Advisors LLC Buys Shares of 8,014 CVS Health Co. (NYSE:CVS)

Simon Quick Advisors LLC purchased a new position in CVS Health Co. (NYSE:CVS) in the first quarter, according to its most recent disclosure with the SEC. The institutional investor purchased 8,014 shares of the pharmacy operator’s stock, valued at approximately $543,000.

A number of other institutional investors also recently made changes to their positions in CVS. Stonebridge Financial Group LLC acquired a new stake in shares of CVS Health during the fourth quarter valued at approximately $28,000. Hopwood Financial Services Inc. acquired a new position in CVS Health in the 4th quarter valued at approximately $29,000. McIlrath & Eck LLC increased its stake in shares of CVS Health by 32.6% during the 4th quarter. McIlrath & Eck LLC now owns 707 shares of the pharmacy operator’s stock worth $32,000 after purchasing an additional 174 shares during the last quarter. MV Capital Management Inc. increased its stake in shares of CVS Health by 63.9% during the 1st quarter. MV Capital Management Inc. now owns 741 shares of the pharmacy operator’s stock worth $50,000 after purchasing an additional 289 shares during the last quarter. Finally, Financial Perspectives Inc increased its stake in shares of CVS Health by 137.5% during the 4th quarter. Financial Perspectives Inc now owns 805 shares of the pharmacy operator’s stock worth $36,000 after purchasing an additional 466 shares during the last quarter. 80.66% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at CVS Health

In other news, Director Guy P. Sansone bought 1,570 shares of the business’s stock in a transaction on Thursday, June 5th. The stock was acquired at an average price of $63.70 per share, with a total value of $100,009.00. Following the completion of the purchase, the director now directly owns 12,007 shares in the company, valued at $764,845.90. This represents a 15.04% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. 1.22% of the stock is owned by insiders.

Analyst Ratings Changes

A number of analysts have weighed in on CVS shares. Wall Street Zen raised shares of CVS Health from a “hold” rating to a “buy” rating in a report on Friday, May 9th. Mizuho increased their price objective on shares of CVS Health from $70.00 to $76.00 and gave the stock an “outperform” rating in a report on Wednesday, April 9th. Cowen reaffirmed a “buy” rating on shares of CVS Health in a research note on Monday, May 5th. Argus set a $77.00 target price on shares of CVS Health in a research note on Tuesday, February 18th. Finally, Barclays set a $79.00 price objective on shares of CVS Health and gave the stock an “overweight” rating in a research note on Monday, June 2nd. Two research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $74.75.

CVS Health Price Performance

Shares of NYSE:CVS opened at $67.42 on Friday. The stock has a market cap of $85.29 billion, a PE ratio of 18.42, a price-to-earnings-growth ratio of 0.98 and a beta of 0.56. CVS Health Co. has a 1-year low of $43.56 and a 1-year high of $72.51. The company has a current ratio of 0.81, a quick ratio of 0.60 and a debt-to-equity ratio of 0.80. The stock’s fifty day simple moving average is $65.15 and its two-hundred day simple moving average is $60.15.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.62 by $0.63. CVS Health had a return on equity of 9.11% and a net margin of 1.24%. The business had revenue of $94.59 billion for the quarter, compared to analysts’ expectations of $93.07 billion. During the same period in the previous year, the business posted $1.31 EPS. The firm’s quarterly revenue was up 7.0% compared to the same quarter last year. As a group, analysts forecast that CVS Health Co. will post 5.89 EPS for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, May 1st. Stockholders of record on Tuesday, April 22nd were issued a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 3.95%. The ex-dividend date was Tuesday, April 22nd. CVS Health’s payout ratio is 63.48%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.